FDA Clears Exact Sciences Next-Generation Colorectal Cancer Diagnostic Test
| EXAS Stock | USD 58.10 1.30 2.19% |
Slightly above 76 percent of EXACT Sciences' private investors are selling. The analysis of the overall investor sentiment regarding EXACT Sciences suggests that a fairly large number of traders are terrified. EXACT Sciences' investing sentiment can be driven by a variety of factors including economic data, EXACT Sciences' earnings reports, geopolitical events, and overall market trends.
EXACT |
On Friday, the FDA approved Exact Sciences Corp.s Cologuard Plus test, the companys next-generation multi-target stool DNA test. The Cologuard Plus test is now approved for adults ages 45 and older who are at average risk for colorectal cancer . FDA approval was based on findings from the pivotal BLUE-C study, one of the largest prospective, head-to-head studies ever conducted in CRC screening. Among the subset of nearly 19,000 average-risk participants, the Cologuard Plus t
Read at finance.yahoo.com
 |
EXACT Sciences Current Investor Sentiment
Panic Vs Confidence
24
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use EXACT Sciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward EXACT Sciences.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentDisposing |
EXACT Sciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards EXACT Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
EXACT Sciences Fundamental Analysis
We analyze EXACT Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EXACT Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EXACT Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
EXACT Sciences is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
EXACT Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with EXACT Sciences stock to make a market-neutral strategy. Peer analysis of EXACT Sciences could also be used in its relative valuation, which is a method of valuing EXACT Sciences by comparing valuation metrics with similar companies.
Peers
EXACT Sciences Related Equities
| RCUS | Arcus Biosciences | 2.90 | ||||
| CRBU | Caribou Biosciences | 0.00 | ||||
| FATE | Fate Therapeutics | 1.79 | ||||
| KPTI | Karyopharm Therapeutics | 7.03 | ||||
| XFOR | X4 Pharmaceuticals | 8.11 | ||||
| HOOK | Hookipa Pharma | 9.41 |
Additional Tools for EXACT Stock Analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.